The global metabolic testing market is expected to reach $475.75 million by 2019 from $332.78 million in 2014, growing at a CAGR of 7.41% between 2014 and 2019. Rising prevalence of lifestyle diseases is the primary growth driver for this market during the forecast period (2014–2019). Moreover, technological advancements and increasing healthcare expenditure are also expected to drive market growth. However, high cost of equipment and software and reimbursement issues may hinder the growth of this market.

https://www.marketsandmarkets.com/Market-Reports/metabolic-testing-equipment-market-149228862.html

The global metabolic testing market is segmented on the basis of products, technologies, applications, end users, and regions. On the basis of products, the market is segmented into CPET systems, metabolic carts, ECGs and EKGs, body composition analyzers, and software. By technology, the market is divided into VO2 max analysis, RMR analysis, and body composition analysis. By application, the market is divided into lifestyle diseases, critical care, human performance testing, dysmetabolic syndrome X, metabolic disorders, and other applications. By end user, the market is segmented into hospitals, laboratories, sports training centers, gyms, and other end users.

The geographic segments included in the report are Asia, Europe, North America, and the Rest of the World (RoW). Geographic analysis reveals that North America accounted for the largest share of the global metabolic market in 2014. Growth in this market can be attributed to the rising prevalence of lifestyle diseases. The Asian regional segment, on the other hand, is expected to register a higher growth rate from 2014 to 2019, owing to the rising standard of living, growing demand for quality medical care, increasing healthcare spending, government initiatives, and enhanced awareness about healthcare in this region.

The major players of this market are CareFusion Corporation (U.S.), MGC Diagnostics Corporation (U.S.), COSMED (Italy), CORTEX Biophysik GmbH (Germany), Geratherm Medical AG (Germany), General Electric Company (U.S.), OSI Systems, Inc. (U.S.), KORR Medical Technologies, Inc. (U.S.), AEI Technologies, Inc. (U.S.), Parvo Medics (U.S.), and Microlife Medical Home Solutions, Inc. (U.S.).